Navigation Links
Two-Year Data Reinforce Effect of ACTEMRA(R) (tocilizumab) in Inhibiting Progression of Joint Damage and Improving Physical Function in Rheumatoid Arthritis Patients
Date:5/24/2009

t-modified Sharp score, compared with 67 percent of patients treated with placebo plus methotrexate.

ACTEMRA was generally well tolerated; the most common adverse events reported most frequently in the ACTEMRA arms of the LITHE study were serious infections.

About ACTEMRA(R) (tocilizumab)

ACTEMRA is the first humanized interleukin-6 (IL-6) receptor-inhibiting monoclonal antibody being studied for the treatment of RA. Studies demonstrate that reducing the activity of IL-6, one of several key cytokines involved in the inflammatory process, relieves both inflammation of the joints and certain systemic effects of RA. The extensive clinical development program conducted by Roche includes five Phase III clinical studies and has enrolled more than 4,000 patients in 41 countries, including the United States. The five Phase III studies are completed and have reported meeting their primary endpoints. ACTEMRA is currently under review by the FDA in the United States.

ACTEMRA is part of a co-development agreement between Roche and Chugai Pharmaceutical Co. In June 2005, ACTEMRA was launched by Chugai in Japan as a therapy for Castleman's disease; in April 2008, additional indications for rheumatoid arthritis, juvenile idiopathic arthritis and systemic-onset juvenile idiopathic arthritis were also approved in Japan. ACTEMRA (known as RoACTEMRA in Europe), was also recently approved in the European Union, Switzerland and India.

The serious adverse events reported in ACTEMRA clinical studies include serious infections, gastrointestinal perforations and hypersensitivity reactions including anaphylaxis. The most common adverse events reported in clinical studies were upper respiratory tract infection, nasopharyngitis, headache, hypertension and increased ALT. Increases in liver enzymes (ALT and AST) were seen in patients; these increases were generally mild and
'/>"/>

SOURCE Roche
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Two-Year Phase III Data Presented at AAN 61st Annual Meeting Show Positive Outcome of Cladribine Tablets in Patients With Multiple Sclerosis
2. The Lancet Publishes Two-Year Results of Abbotts Fully Bioabsorbable Drug Eluting Stent
3. Circulation Publishes Pivotal Two-Year Results On XIENCE V(TM) Drug Eluting Stent
4. Two-Year Follow-Up Data Demonstrates Preservation of Adequate Mitral Valve Area in Patients Treated with the MitraClip(R) System
5. XTENT Announces Positive Two-Year CUSTOM I and One-Year CUSTOM II Trial Data for Novel Drug-Eluting Stent System
6. Two-Year Outcomes From Large Head-to-Head Clinical Trial Indicate Similar Safety Profile in Diabetic Patients for Cypher(R) Sirolimus-Eluting Coronary Stent and Taxus Stent
7. Clinical Data Reinforce Safety and Efficacy of Boston Scientifics Two Drug- Eluting Stent Platforms
8. Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientifics Next-Generation Taxus Liberte Stent
9. Secretary Reinforces VAs Commitment to Research Safety and Veteran Focus
10. Stereotaxis Market Leadership Reinforced in Core Curriculum and Symposium Presentations at Heart Rhythm 2008
11. Multiple Studies Presented at San Antonio Breast Cancer Symposium Reinforce Clinical Utility of Oncotype DX(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... -- According to Kalorama Information, electronic medical records (EMR) ... in healthcare a reality, and this a factor that ... Recovery and Reinvestment Act, the U.S. government dedicated $20.6 ... will start applying soon for use of paper records.  ... of the EMR industry, EMR 2014: The Market ...
(Date:8/19/2014)... 2014  Cardiva Medical, Inc. announced today that it ... million Series 3 private equity financing and a $12.5 ... will use the proceeds of the Series 3 private ... for its VASCADE® Vascular Closure System in ... in Series 3 private equity financing was a new ...
(Date:8/19/2014)... , Aug. 19, 2014  Regeneron Pharmaceuticals, Inc. (NASDAQ: ... conferences: , Sanofi and Regeneron will host an IR ... on Tuesday, September 2, 2014 , Baird 2014 ... September 3, 2014 , Citi,s 9 th ... Thursday, September 4, 2014 , Morgan Stanley Global ...
Breaking Medicine Technology:Kalorama: EMR Paves the Way for Big Data 2Kalorama: EMR Paves the Way for Big Data 3Cardiva Medical, Inc. Announces Completion of the first two tranches of Series 3 Private Equity Financing and the Closing of a Senior Secured Debt Facility with GE Capital 2
(Date:8/20/2014)... (PRWEB) August 20, 2014 BuyCheapTicketsToEvents.com ... a wide selection of tickets to many events. Cheap NHL ... will begin in September. , Hockey fans are enthusiastic about ... obtain tickets for games. Now is the time to acquire ... begin in mere months. There will be a great deal ...
(Date:8/20/2014)... people grow older, they often have difficulty falling asleep ... in the morning. In individuals with Alzheimer,s disease, this ... especially pronounced, often leading to nighttime confusion and wandering. ... Israel Deaconess Medical Center (BIDMC) and the University of ... more fragmented with age. Reported online today in the ...
(Date:8/20/2014)... Mixberry Media announced today its new ... create a new source of revenue. , The innovative ... to a narration of their favorite news and articles ... Users can now multitask: read/write email, drink coffee, ... content. , Mixberry Media’s service converts news ...
(Date:8/20/2014)... August 20, 2014 Riverside Health System ... , who joined its Warsaw Medical Arts team earlier ... in Family Medicine, is accepting new patients. , Dameron, ... Medicine, completed his residency at the Mountain Area Health ... Virginia. , “I really like the rural aspect of ...
(Date:8/19/2014)... 20, 2014 As moms and dads prepare ... to return to the normal routine of dropping their little ... Kristen Yarker, MSc, RD encourages them to use the ... snack time. , Yarker explains, “Kids have small tummies, ... of giving them junk food handouts, use snack time as ...
Breaking Medicine News(10 mins):Health News:2014 NHL Preseason Tickets Are Among Top Selling Seats at Trusted Provider BuyCheapTicketsToEvents.com 2Health News:Research helps explain why elderly have trouble sleeping 2Health News:Research helps explain why elderly have trouble sleeping 3Health News:Mixberry Media, First To Offer Article Voice Narration with Integrated Audio Advertising 2Health News:Riverside Warsaw Medical Arts’ Dr. William Dameron Accepting New Patients 2Health News:Child Nutritionist Kristen Yarker Wants Parents to Rethink Kids’ Snacks This Fall 2Health News:Child Nutritionist Kristen Yarker Wants Parents to Rethink Kids’ Snacks This Fall 3
... FirmsPHILADELPHIA, Jan. 15 /PRNewswire/ -- Michael ... Centocor, Inc., an operating company of Johnson & ... public relations consultancy, Pitch360 Incorporated ( www.pitch360inc.com ). ... issues management consultancy that leverages its vast pharmaceutical ...
... aging causes broken bones to heal slowly, or not at ... Journal of Bone and Mineral Research . The research team ... of treatments designed to "rescue" healing capability lost to aging. ... healing keeps the two sides of a fractured bone from ...
... Enterprises Ltd. ("Beeston") (OTC-BB:BESE) a resource base company ... mineral properties, announced that its Board of Directors ... of its full media campaign. MicroCap Management has ... a launch pad for Beeston,s present and future ...
... Area Treatments Twice as Fast and Improves Patient Treatment ... SLTM ) today announced the launch of ... system for faster, more comfortable body shaping, contouring and ... of traditional Thermage tips, Body Tip 16.0 cuts body ...
... WINSTON-SALEM, N.C., Jan. 15 For consumers, the Internet,offers ... vacations; however,when it comes to finding the best doctor, ... days, there are Web sites that offer ratings on,everyone ... picking,the best restaurants and hotels in town are getting ...
... Outlines Steps Taken to Reduce Expenses in Light ... Mass., Jan. 15 Cynosure, Inc. (NASDAQ: ... of a broad array of light-based aesthetic treatment ... fourth quarter ended December 31, 2008.Cynosure expects to ...
Cached Medicine News:Health News:Former Johnson & Johnson Executive Gives Big Voice to Small Companies 2Health News:Researchers detail how aging undermines bone healing 2Health News:Researchers detail how aging undermines bone healing 3Health News:Researchers detail how aging undermines bone healing 4Health News:Beeston Retains MicroCap Management, LLC as Its Lead Corporate Communications and Broker Relations Firm 2Health News:Beeston Retains MicroCap Management, LLC as Its Lead Corporate Communications and Broker Relations Firm 3Health News:Video: Solta Medical Introduces Advanced Thermage Body Tip 16.0 for Faster Body Shaping and Contouring Treatments 2Health News:Video: Solta Medical Introduces Advanced Thermage Body Tip 16.0 for Faster Body Shaping and Contouring Treatments 3Health News:DrScore.com Says: Know Your Source When Going Online To Review Your Doctor's Rating 2Health News:DrScore.com Says: Know Your Source When Going Online To Review Your Doctor's Rating 3Health News:Cynosure Provides Preliminary Financial Results for the Fourth Quarter of 2008 2Health News:Cynosure Provides Preliminary Financial Results for the Fourth Quarter of 2008 3Health News:Cynosure Provides Preliminary Financial Results for the Fourth Quarter of 2008 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: